Skip to main content
. 2023 Oct 31;12(4):257–268. doi: 10.7762/cnr.2023.12.4.257

Table 1. Baseline characteristics of participants.

Variables Co-Q10 (n = 39) Placebo (n = 38) p value
Age (yr) 33.44 ± 7.30 33.97 ± 8.28 0.763
Marital status 0.391
Single 8 (20.5) 11 (28.9)
Married 31 (79.5) 27 (71.1)
Positive migraine family history* 24 (61.5) 26 (68.4) 0.527
Years with migraine 11.51 ± 7.47 9.07 ± 6.46 0.129
Migraine with aura* 11 (28.2) 11 (28.9) 0.943
Body mass index 25.78 ± 4.03 25.08 ± 3.84 0.436
Body fat percentage 32.94 ± 5.84 31.07 ± 6.52 0.188
Waist circumference 83.05 ± 8.86 81.24 ± 8.60 0.365
Hip circumference 103.77 ± 7.61 101.82 ± 6.91 0.243
Physical activity level* 0.957
High 0 (0) 0 (0)
Moderate 7 (17.9) 7 (18.4)
Low 32 (82.1) 31 (81.6)

Values are presented as number (%) or mean ± standard deviation.

Co-Q10, Coenzyme Q10.

*The p value is reported based on the analysis of χ2 test.

The p value is reported based on the analysis of independent sample t-test.